Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
56.9M
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
19.6M
-
Shares change
-
+126K
-
Total reported value, excl. options
-
$485M
-
Value change
-
+$3.58M
-
Number of buys
-
34
-
Number of sells
-
-32
-
Price
-
$24.69
Significant Holders of GLAUKOS Corp - Common Stock (GKOS) as of Q4 2015
76 filings reported holding GKOS - GLAUKOS Corp - Common Stock as of Q4 2015.
GLAUKOS Corp - Common Stock (GKOS) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.6M shares
of 56.9M outstanding shares and own 34.47% of the company stock.
Largest 10 shareholders include Versant Venture Management, LLC (3.14M shares), Meritech Capital Associates III L.L.C. (3.03M shares), ORBIMED ADVISORS LLC (2.9M shares), FRAZIER MANAGEMENT LLC (2.6M shares), LORD, ABBETT & CO. LLC (1.3M shares), Capital World Investors (1.28M shares), GILDER GAGNON HOWE & CO LLC (798K shares), ALLIANCEBERNSTEIN L.P. (684K shares), WELLS FARGO & COMPANY/MN (646K shares), and VANGUARD GROUP INC (509K shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.